Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001644087-26-000002

CMO sold 21,338 shares at $32.12 ($685,308)

  • CMO acquired 21,338 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Donovan Joanne M. · CMO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-31 Exercise or conversion : show line 1 in the form 10b5-1 +21,338 $7.08 $151,073 30,935 D
2026-03-31 Sale : show line 2 in the form 10b5-1 −21,338 $32.12 $685,308 9,597 D
Open-market sales · 21,338 sh · avg $32.12 · $685,308

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-31 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −21,338 153,662 D
Loading xslF345X06/primarydocument.xml…